Biotech Takeover Targets Wall Street Eyes After Apogee Deal
AbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
Which is more tax-efficient for retirement: ETF or mutual fund? A clear comparison of tax features and practical implications.
28,114 articlesAbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
America’s debt has surged to WWII-era levels even as growth accelerates. Here’s what the numbers show and why investo...
A fresh take on dine brands (din) 2025, focusing on Q4 signals, brand momentum, and how investors can position themse...
Qualcomm is trading at a discount to peers while building a strong AI silicon footprint. With a June Investor Day and...
In a choppy 2026 market, Cathie Wood isn’t chasing high-flying tech alone. She’s quietly adding to positions in three...
A wave of billionaire fund managers are boosting Amazon bets as AI hype collides with a value play. Pershing Square, ...
SK Hynix kicked off trading on Wall Street with a double-digit rally, marking the largest U.S. IPO by a foreign compa...
Ethereum closes a seventh consecutive red month as whales reel in risk, even as on-chain Real World Assets push past ...
A lesser-known chip stock is catching the AI wave’s spotlight. This article breaks down why it’s rallying, what fuels...
Kenya's High Court halted a U.S. plan to establish a quarantine facility for Americans exposed to Ebola, delaying a $...
Salesforce CRM faces a sharp sell-off even as its AI strategy shows real monetization. Here’s why traders are watchin...
Lucid shares sank as new reports claim the EV maker is weighing drastic options, including a take-private or Chapter ...